Relationship of Serum Antileishmanial Antibody With Development of Visceral Leishmaniasis, Post-kala-azar Dermal Leishmaniasis and Visceral Leishmaniasis Relapse

IntroductionTo sustain the achievement of kala-azar elimination program (KEP), early detection and treatment of the visceral leishmaniasis (VL) cases and associated modalities such as treatment failure (TF), relapse VL (RVL), and Post-kala-azar dermal leishmaniasis (PKDL) is the cornerstone. A predi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Dinesh Mondal, Prakash Ghosh, Rajashree Chowdhury, Christine Halleux, Jose A. Ruiz-Postigo, Abdul Alim, Faria Hossain, Md Anik Ashfaq Khan, Rupen Nath, Malcolm S. Duthie, Axel Kroeger, Greg Matlashewski, Daniel Argaw, Piero Olliaro
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2019-10-01
Colección:Frontiers in Microbiology
Materias:
visceral leishmaniasis (VL)
treatment failure (TF)
relapse VL (RVL)
Post-kala-azar dermal leishmaniasis (PKDL)
rK39 antibody
ELISA
Acceso en línea:https://www.frontiersin.org/article/10.3389/fmicb.2019.02268/full
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares